Efficacy Ezetimibe for dyslipidemia: A prospective cohort study

Efficacy Ezetimibe for dyslipidemia: A prospective cohort study - Efficacy Ezetimibe for dyslipidemia: A prospective cohort study

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037604

Enrollment

100

Registered

2019-08-06

Start date

2018-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia during statin treatment

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dyslipidemia using statin

Exclusion criteria

Exclusion criteria: Patients who were deemed not appropriate to participate in this study by doctor

Design outcomes

Primary

Measure	Time frame
LDL	—

Secondary

Measure	Time frame
1) HDL, T-cho, TG 2) BUN, Cr, AST, ALT, CK, HbA1c 3) cystatin C, oxidized LDL, fatty acid fractionation, Lp (a), 4) Lipo fractionation, remnant-Like Particle 5) FMD, carotid echo, ABI 6) Cardiovascular events	—

Countries

Japan

Contacts

Public ContactAkira Sezai

Nihon University School of Medicine Department of Cardiovascular Surgery

asezai.med@gmail.com03-3972-8111

Outcome results